Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Treasury Shares (2016 - 2025)

Medifast (MED) has disclosed Treasury Shares for 11 consecutive years, with $6.4 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Treasury Shares changed N/A year-over-year to $6.4 million, compared with a TTM value of $6.4 million through Dec 2022, changed N/A, and an annual FY2022 reading of $6.4 million, changed N/A over the prior year.
  • Treasury Shares was $714000.0 for Q3 2025 at Medifast, down from $722000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $722000.0 in Q2 2025 and bottomed at $44.0 in Q2 2021.
  • Average Treasury Shares over 5 years is $219565.2, with a median of $90500.0 recorded in 2021.
  • The sharpest move saw Treasury Shares soared 4017.2% in 2019, then tumbled 92.19% in 2020.
  • Year by year, Treasury Shares stood at $30.9 million in 2018, then surged by 107.24% to $64.0 million in 2019, then crashed by 92.19% to $5.0 million in 2020, then crashed by 73.06% to $1.3 million in 2021, then soared by 374.98% to $6.4 million in 2022.
  • Business Quant data shows Treasury Shares for MED at $6.4 million in Q4 2022, $1.3 million in Q2 2021, and $12.5 million in Q1 2021.